30-year-old pregnant woman after mitral valve replacement Case report
Article Sidebar
Main Article Content
Abstract
This article presents the case of a 30-year-old pregnant woman after mitral St. Jude Medical 29 mm Silzone valve replacement due to mitral regurgitation during infective endocarditis four years ago. The patient was admitted to hospital to make a decision about antithrombotic treatment during the first trimester of pregnancy. This report underlines the difficulties in the antithrombotic treatment during pregnancy.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Vitale N., De Feo M., De Santo L.S.: Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J. Am. Coll. Cardiol. 1999, 33: 1486-1588.
3. Guidelines on the management of valvular heart disease. The task force of the management of valvular heart disease of the European Society of Cardiology. Eur. Heart J. 2007, 28: 230-268.
4. Oakley C., Child A., Iung B., Presbitero P., Tornos P.: Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management o cardiovascular diseases during pregnancy. Eur. Heart J. 2003, 24: 761-781.
5. Butchart E.G., Gohlke-Barwolf C., Antunes M.J., Tornos P., De Caterina R., Cormier B., Prendergast B., Iung B., Bjornstad H., Leport C., Hall R.J., Vahanian A.; Working Groups on Valvular Heart Disease, Thrombosis, Cardiac Rehabilitation, Exercise Physiology, European Society of Cardiology: Recommendations for the management of patients after heart valve surgery. Eur. Heart J. 2005, 26: 2463-2471.
6. Bozkurt B., Villaneuva F.S., Holubkov R. et al.: Intravenous Immune globulin in the therapy of peripartum cardiomyopathy. J. Am. Coll. Cardiol. 1999, 34: 177-80.